
AL 27 Tablet
Marketer
Acron Pharmaceuticals
Salt Composition
Albendazole (NA)
Overview AL 27 Tablet
Parasitic worm infections respond to treatment with AL 27 Tablet, an antiparasitic medication. Its mechanism of action involves eliminating the infecting worms, thereby halting infection spread. Dosage and treatment duration for AL 27 Tablet should strictly adhere to your physician's instructions. Ingestion may occur with or without food, ideally at a consistent time. Consistent medication intake is crucial; complete the prescribed course even with symptom improvement. Missed doses should not be compensated with doubled doses; simply resume the normal schedule. Potential side effects include nausea, vomiting, dizziness, elevated liver enzymes, and appetite suppression. Prolonged side effects warrant immediate medical consultation. Blood work and liver function tests may be conducted during treatment for monitoring purposes.
Uses of AL 27 Tablet
Managing parasitic infestations
Major Benefits of AL 27 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. AL 27 Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of AL 27 Tablet:
- Vomiting
- Dizziness
- Increased liver enzymes
- Nausea
- Loss of appetite
How to use AL 27 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. AL 27 Tablets can be ingested with or without food, though consistent timing is recommended.
How AL 27 Tablet works:
AL 27 Tablet combats parasitic infections by targeting the worms' glucose uptake. This disruption of their energy supply leads to parasite death and subsequent resolution of the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside AL 27 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of AL 27 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
AL 27 Tablet is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Taking AL 27 Tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Use of AL 27 Tablet in individuals with kidney disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use AL 27 Tablet cautiously, potentially requiring dosage modification. Consult your physician. Report any jaundice symptoms—yellow skin or eyes, pruritus, or pale stools—to your doctor immediately while using this medication.
What if you forget to take AL 27 Tablet :
Should you forget to take your AL 27 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About AL 27 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-2-yl carbamate esters |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Drugs against protozoa |
